Error loading player: No playable sources found

Technical Seminar Sponsored by SCIEX: Are Off-The-Shelf Formulation Buffers Suitable for Your Biotherapeutic Protein? The Effect of Buffer Formulations on Antibodies’ Proteoforms Relative Abundances

Date
September 15, 2020
Explore related products in the following collection:
Thumbnail for Mass Spec 2020
The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry. Mass Spectrometry is a critical analytical technology used in the discovery, development, and commercialization of biopharmaceuticals…

A number of buffers, approved by the FDA/EMA, are sold as being suitable for the formulation of antibody therapeutics. These buffers cover a wide range of substances, pH, salts, amino acids, sugars, and detergents.

Some of them have been optimized for certain antibodies in particular. Typically, pre-formulation of Abs starts at these sets of buffers, followed by further improving the conditions of a few selected buffers thereafter. However, to our knowledge, there is no study that has assessed the effect of these buffer formulations on the relative amounts of the antibody modifications (i.e., glycosylation, oxidation and others). Here we present a multiple attribute methodology (MAM) workflow on intact proteins upon reconstruction of data (intact MAM) using liquid chromatography coupled to high resolution mass spectrometry (LC-MS). For this study the effects of 96 commercially available buffer formulations were assessed focusing on the relative abundances of endogenous modifications of the Trastuzumab and our inhouse antibody 17b. For the evaluation, an LC-MS method and data processing workflow for intact MAM were established. Results are presented for a time course study of 7 days of storage at multiple temperatures determining the effect of the different formulations with the optimized method enabling the throughput needed.

Moderator

Speaker

Speaker Image for Victor Solis
EpiQMAx GmbH

Related Products

Thumbnail for Keynote Session II: Spontaneous Modifications in Long-Lived Proteins: Structural and Biological Implications
Keynote Session II: Spontaneous Modifications in Long-Lived Proteins: Structural and Biological Implications
Long-lived proteins such as alpha-synuclein, A-beta, and tau are subject to a variety of spontaneous chemical modifications. These modifications accumulate over time without the need for enzymatic catalysis…
Thumbnail for Keynote Session IV: Multiplexing the Orbitrap to Readout Individual Ion Mass Spectra of Virus-Like Particles
Keynote Session IV: Multiplexing the Orbitrap to Readout Individual Ion Mass Spectra of Virus-Like Particles
A new readout for individual ions in orbitraps has recently been reported in the April 2020 cover article in Nature Methods…